Skip to main content

Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion

18Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Preimplantation genetic testing for monogenic diseases for adult-onset conditions is ethically permissible for a range of conditions including when the condition is serious and no safe, effective interventions are available. The Committee strongly recommends that a genetic counselor experienced with PGT-M counsel patients considering such procedures. This document replaces the document titled “Use of preimplantation genetic diagnosis for serious adult-onset conditions: a committee opinion,” last published in Fertil Steril 2013;100;54-7. Earn online CME credit related to this document at www.asrm.org/elearn

Cite

CITATION STYLE

APA

Daar, J., Benward, J., Collins, L., Davis, J., Davis, O., Francis, L., … Zweifel, J. (2018). Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion. Fertility and Sterility, 109(6), 989–992. https://doi.org/10.1016/j.fertnstert.2018.04.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free